Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

735
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
735
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

448
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
448
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

462
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
462
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

985
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
985
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

629
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
629

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing mentorship/sponsorship opportunities for pulmonary, critical care and sleep fellows through structured alumni engagement.

BMJ leader·2026
Same author

Interoception and eating behavior in participants at risk for hypertensive disorders of pregnancy.

Journal of complementary & integrative medicine·2025
Same author

Sleep is an opportunity to reduce pregnancy-related severe morbidity and mortality.

Obstetric medicine·2025
Same author

Obstructive sleep apnea in pregnancy: emerging insights into maternal and fetal outcomes.

Current opinion in pulmonary medicine·2025
Same author

Psychological mechanisms of prenatal mindfulness training on antenatal blood pressure reduction: A pilot study.

Journal of psychosomatic research·2025
Same author

Impact of Asthma and Obstructive Sleep Apnea on Central Airways Resistance During Pregnancy.

Lung·2025

Related Experiment Video

Updated: Feb 6, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

867

Pregnancy and Pulmonary Embolism.

Christopher Deeb Dado1, Andrew Tobias Levinson2, Ghada Bourjeily3

  • 1Pulmonary and Critical Care Fellowship, Rhode Island Hospital, Warren Alpert Medical School of Brown University, 593 Eddy Street, Providence, RI 02903, USA.

Clinics in Chest Medicine
|August 21, 2018
PubMed
Summary

Pregnancy increases the risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, due to factors like the Virchow triad. Risk assessment and tailored prevention are crucial during and after pregnancy.

Keywords:
HeparinMultidetector CTPregnancyPulmonary embolismVenous thromboembolismVentilation perfusion scan

More Related Videos

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

850
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K

Related Experiment Videos

Last Updated: Feb 6, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

867
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

850
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Venous thromboembolism (VTE) is a significant cause of mortality in pregnant individuals.
  • Risk factors include the Virchow triad, inherited thrombophilias, and standard risk factors.
  • The elevated risk persists for 6-12 weeks postpartum.

Purpose of the Study:

  • To highlight the increased risk of VTE during pregnancy and the postpartum period.
  • To emphasize the need for risk stratification and preventive measures.
  • To underscore the importance of understanding diagnostic and treatment modifications for VTE in pregnancy.

Main Methods:

  • Review of current literature on VTE in pregnancy.
  • Analysis of risk factors contributing to peripartum VTE.
  • Comparison of standard VTE diagnostic and treatment protocols with those adapted for pregnancy.

Main Results:

  • Pregnancy is associated with a heightened risk of VTE, encompassing deep vein thrombosis and pulmonary embolism.
  • Risk factors are multifactorial, involving physiological changes (Virchow triad), genetic predispositions, and other clinical factors.
  • Diagnostic approaches and therapeutic strategies for VTE require specific considerations during pregnancy.

Conclusions:

  • Effective management of peripartum VTE necessitates individualized risk assessment and timely intervention.
  • Healthcare providers must be aware of the unique challenges in diagnosing and treating VTE in pregnant patients.
  • Understanding the nuances of VTE management in pregnancy is critical for improving maternal outcomes.